Loading…

Structure activity relationships of quinoline-containing c-Met inhibitors

A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the import...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2008-06, Vol.43 (6), p.1321-1329
Main Authors: Kung, Pei-Pei, Funk, Lee, Meng, Jerry, Alton, Gordon, Padrique, Ellen, Mroczkowski, Barbara
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3
cites cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3
container_end_page 1329
container_issue 6
container_start_page 1321
container_title European journal of medicinal chemistry
container_volume 43
creator Kung, Pei-Pei
Funk, Lee
Meng, Jerry
Alton, Gordon
Padrique, Ellen
Mroczkowski, Barbara
description A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site. [Display omitted]
doi_str_mv 10.1016/j.ejmech.2007.08.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71617208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523407003339</els_id><sourcerecordid>71617208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</originalsourceid><addsrcrecordid>eNp9kE1rFEEURQtRzCT6D0R6o7tuX333bAQJagIRF-q6qK5-7byhp2pSVR3Iv7fDDLpz9bhw7uVxGHvDoePAzYd9h_sDhl0nAGwHfQecP2Mbbk3fSqHVc7YBIWSrhVQX7LKUPQBoA_CSXXC7NWqNG3b7o-Yl1CVj40OlB6qPTcbZV0qx7OhYmjQ19wvFNFPENqRYPUWKv5vQfsPaUNzRQDXl8oq9mPxc8PX5XrFfXz7_vL5p775_vb3-dNcGuYXa9hYGs1V2UNIMgXvLp34ycrScD0JoEbhFUHY7jbof-oAKQUttufZSWdl7ecXen3aPOd0vWKo7UAk4zz5iWoqz3HAroF9BdQJDTqVknNwx08HnR8fBPSl0e3dS6J4UOujdqnCtvT3vL8MBx3-ls7MVeHcGfAl-nrKPgcpfToDiQmqzch9PHK42HgizK4EwBhwpY6huTPT_T_4A66yQpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71617208</pqid></control><display><type>article</type><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><source>ScienceDirect Journals</source><creator>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</creator><creatorcontrib>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</creatorcontrib><description>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site. [Display omitted]</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2007.08.011</identifier><identifier>PMID: 17964000</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Oxford: Elsevier Masson SAS</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; c-Met ; General aspects ; Magnetic Resonance Spectroscopy ; Mass Spectrometry ; Medical sciences ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - chemistry ; Protein Kinase Inhibitors - pharmacology ; Proto-Oncogene Proteins c-met - antagonists &amp; inhibitors ; Quinoline ; Quinolines - pharmacology ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1321-1329</ispartof><rights>2007 Elsevier Masson SAS</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</citedby><cites>FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20412356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17964000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kung, Pei-Pei</creatorcontrib><creatorcontrib>Funk, Lee</creatorcontrib><creatorcontrib>Meng, Jerry</creatorcontrib><creatorcontrib>Alton, Gordon</creatorcontrib><creatorcontrib>Padrique, Ellen</creatorcontrib><creatorcontrib>Mroczkowski, Barbara</creatorcontrib><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site. [Display omitted]</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>c-Met</subject><subject>General aspects</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mass Spectrometry</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - chemistry</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Proto-Oncogene Proteins c-met - antagonists &amp; inhibitors</subject><subject>Quinoline</subject><subject>Quinolines - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rFEEURQtRzCT6D0R6o7tuX333bAQJagIRF-q6qK5-7byhp2pSVR3Iv7fDDLpz9bhw7uVxGHvDoePAzYd9h_sDhl0nAGwHfQecP2Mbbk3fSqHVc7YBIWSrhVQX7LKUPQBoA_CSXXC7NWqNG3b7o-Yl1CVj40OlB6qPTcbZV0qx7OhYmjQ19wvFNFPENqRYPUWKv5vQfsPaUNzRQDXl8oq9mPxc8PX5XrFfXz7_vL5p775_vb3-dNcGuYXa9hYGs1V2UNIMgXvLp34ycrScD0JoEbhFUHY7jbof-oAKQUttufZSWdl7ecXen3aPOd0vWKo7UAk4zz5iWoqz3HAroF9BdQJDTqVknNwx08HnR8fBPSl0e3dS6J4UOujdqnCtvT3vL8MBx3-ls7MVeHcGfAl-nrKPgcpfToDiQmqzch9PHK42HgizK4EwBhwpY6huTPT_T_4A66yQpg</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Kung, Pei-Pei</creator><creator>Funk, Lee</creator><creator>Meng, Jerry</creator><creator>Alton, Gordon</creator><creator>Padrique, Ellen</creator><creator>Mroczkowski, Barbara</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Structure activity relationships of quinoline-containing c-Met inhibitors</title><author>Kung, Pei-Pei ; Funk, Lee ; Meng, Jerry ; Alton, Gordon ; Padrique, Ellen ; Mroczkowski, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>c-Met</topic><topic>General aspects</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mass Spectrometry</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - chemistry</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Proto-Oncogene Proteins c-met - antagonists &amp; inhibitors</topic><topic>Quinoline</topic><topic>Quinolines - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kung, Pei-Pei</creatorcontrib><creatorcontrib>Funk, Lee</creatorcontrib><creatorcontrib>Meng, Jerry</creatorcontrib><creatorcontrib>Alton, Gordon</creatorcontrib><creatorcontrib>Padrique, Ellen</creatorcontrib><creatorcontrib>Mroczkowski, Barbara</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kung, Pei-Pei</au><au>Funk, Lee</au><au>Meng, Jerry</au><au>Alton, Gordon</au><au>Padrique, Ellen</au><au>Mroczkowski, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure activity relationships of quinoline-containing c-Met inhibitors</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>43</volume><issue>6</issue><spage>1321</spage><epage>1329</epage><pages>1321-1329</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>A series of quinoline-containing c-Met inhibitors were prepared and studied. Chemistry was developed to introduce a pyridyl moiety onto the 2-aryl ring present in a lead molecule which mitigated the potential for quinone formation relative to the original compound. The study also assessed the importance of an acylthiourea moiety present in the lead structure for effective binding to the c-Met protein ATP site. [Display omitted]</abstract><cop>Oxford</cop><pub>Elsevier Masson SAS</pub><pmid>17964000</pmid><doi>10.1016/j.ejmech.2007.08.011</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2008-06, Vol.43 (6), p.1321-1329
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_71617208
source ScienceDirect Journals
subjects Antineoplastic agents
Biological and medical sciences
c-Met
General aspects
Magnetic Resonance Spectroscopy
Mass Spectrometry
Medical sciences
Pharmacology. Drug treatments
Protein Kinase Inhibitors - chemistry
Protein Kinase Inhibitors - pharmacology
Proto-Oncogene Proteins c-met - antagonists & inhibitors
Quinoline
Quinolines - pharmacology
Structure-Activity Relationship
title Structure activity relationships of quinoline-containing c-Met inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T00%3A48%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure%20activity%20relationships%20of%20quinoline-containing%20c-Met%20inhibitors&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Kung,%20Pei-Pei&rft.date=2008-06-01&rft.volume=43&rft.issue=6&rft.spage=1321&rft.epage=1329&rft.pages=1321-1329&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2007.08.011&rft_dat=%3Cproquest_cross%3E71617208%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-870b6947b436bc1a71f8f63d711b2252c17e0479fd58b8ce4e0535715a34738a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71617208&rft_id=info:pmid/17964000&rfr_iscdi=true